tiprankstipranks
Laboratorios Farmaceuticos Rovi (ES:ROVI)
:ROVI
Spanish Market

Laboratorios Farmaceuticos Rovi (ROVI) Income Statement

Compare
20 Followers

Laboratorios Farmaceuticos Rovi Income Statement

Last quarter (Q3 2024), Laboratorios Farmaceuticos Rovi's total revenue was €235.28M, an increase of 9.93% from the same quarter last year. In Q3, Laboratorios Farmaceuticos Rovi's net income was €69.15M. See Laboratorios Farmaceuticos Rovi’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 829.51M€ 817.70M€ 648.68M€ 419.96M€ 381.31M
Gross Profit
€ 483.34M€ 519.61M€ 384.82M€ 241.31M€ 214.71M
Operating Expenses
€ 263.09M€ 263.76M€ 203.34M€ 163.88M€ 171.52M
Depreciation and Amortization
€ 24.33M€ 22.87M€ 21.36M€ 19.59M€ 18.22M
EBITDA
€ 245.81M€ 281.49M€ 204.72M€ 93.28M€ 61.22M
Operating Income
€ 220.25M€ 255.85M€ 181.57M€ 74.68M€ 42.84M
Other Income/Expenses
€ 154.00K€ 1.92M€ 1.24M€ -2.07M€ -963.00K
Pretax Income
€ 220.41M€ 257.97M€ 182.63M€ 72.58M€ 41.88M
Net Income
€ 170.34M€ 199.67M€ 153.08M€ 61.06M€ 39.27M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ 3.29€ 3.73€ 2.76€ 1.10€ 0.71
Diluted EPS
€ 3.29€ 3.73€ 2.76€ 1.10€ 0.71
Weighted Average Shares Outstanding
51.82M 53.47M 55.40M 55.39M 55.18M
Weighted Average Shares Outstanding (Diluted)
51.82M 53.47M 55.40M 55.39M 55.18M
Currency in EUR

Laboratorios Farmaceuticos Rovi Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis